Citron Pharma - Generic Products and Related Assets - Ownership and Business Overview

Medical ProductsCompany

Citron Pharma - Generic Products and Related Assets Ownership

Who owns Citron Pharma - Generic Products and Related Assets?

Citron Pharma - Generic Products and Related Assets is owned by ACETO. It was acquired on November 2, 2016.

Citron Pharma - Generic Products and Related Assets Business Overview

Where is Citron Pharma - Generic Products and Related Assets headquartered?

Citron Pharma - Generic Products and Related Assets is headquartered in East Brunswick, New Jersey.

What sector is Citron Pharma - Generic Products and Related Assets in?

Citron Pharma - Generic Products and Related Assets is a medical products company.

Medical Products M&A Summary in 2016

Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2016. The largest medical products acquisition in 2016 was St. Jude Medical - which was acquired by Abbott Laboratories for $25.0B.

Join Mergr to view all 273 acquisitions of medical products companies in 2016, including 32 acquisitions by private equity firms, and 241 by strategics.

Citron Pharma LLC - Generic Products and Related Assets

East Brunswick, New Jersey 08816
United States,

Citron Pharma LLC - Generic Products and Related Assets is a provider of developer of generic products.


 Subscribe to unlock this and 208,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.